| 產(chǎn)品編號(hào) | bs-16960R-Bio |
| 英文名稱1 | Rabbit Anti-BCOX1/Biotin Conjugated antibody |
| 中文名稱 | 生物素標(biāo)記的乳腺癌過表達(dá)基因1蛋白抗體 |
| 別 名 | KIAA0100; Antigen MLAA-22; BCOX; BCOX1; Breast cancer-overexpressed gene 1 protein; CT101; DKFZp686M0843; K0100_HUMAN; KIAA0100; MGC111488; MGC134981; UPF0378 protein KIAA0100. |
| 規(guī)格價(jià)格 | 100ul/2980元 購(gòu)買 大包裝/詢價(jià) |
| 說 明 書 | 100ul |
| 研究領(lǐng)域 | 腫瘤 細(xì)胞生物 腫瘤細(xì)胞生物標(biāo)志物 |
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | Rat, (predicted: Human, Mouse, Cow, ) |
| 產(chǎn)品應(yīng)用 | WB=1:50-200 ELISA=1:100-1000 IHC-P=1:50-200 IHC-F=1:50-200 ICC=1:50-200 IF=1:50-200
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 250kDa |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human BCOX1 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 儲(chǔ) 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存條件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| 產(chǎn)品介紹 |
background: KIAA0100 (KIAA0100) is a Protein Coding gene. Diseases associated with KIAA0100 include Monocytic Leukemia and In Situ Carcinoma. May be involved in membrane trafficking. Subcellular Location: Secreted. Tissue Specificity: Expressed in pancreas, placenta and up-regulated in breast carcinoma epithelial cells, ductal in situ carcinoma (DCIS), invasive breast carcinoma (IBC) and metastatic breast carcinoma cells (MET). Similarity: Belongs to the UPF0378 family. Database links: Entrez Gene: 9703 Human SwissProt: Q14667 Human Unigene: 151761 Human Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
